CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells

Hernan Roca, Zachary S. Varsos, Kenneth J. Pienta

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells'. Together they form a unique fingerprint.

Medicine & Life Sciences